
Mefsprit-P DS Oral Suspension
Marketer
Esprit Lifescience
Salt Composition
Mefenamic Acid (100mg/5ml) + Paracetamol (325mg/5ml)
Overview Mefsprit-P DS Oral Suspension
Combifever-Dual Suspension, a dual-action oral formulation, addresses fever and mild to moderate pain stemming from various sources including headaches, muscle aches, and dental pain. Administer this medication with food to minimize stomach upset. Dosage is determined by your condition and response to treatment, strictly adhering to your physician's instructions. Prolonged use or exceeding the prescribed dose should be avoided. Commonly reported adverse reactions encompass nausea, vomiting, diarrhea, dyspepsia, anorexia, and pyrosis. Should any of these reactions intensify or become problematic, consult your doctor for potential mitigation strategies. Prior to commencing treatment, disclose any pre-existing conditions such as peptic ulcers, gastric bleeding, hypertension, or cardiac, renal, or hepatic impairment. Comprehensive disclosure of all concurrent medications is crucial due to potential interactions.
Primary Ingredients of Mefsprit-P DS Oral Suspension
No information provided. Please provide the text you wish to be rephrased.
Uses of Mefsprit-P DS Oral Suspension
Alleviating pain and reducing fever
Major Benefits of Mefsprit-P DS Oral Suspension:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Always consult the product label for complete instructions prior to consumption. Use a measuring cup for accurate dosing and ingest orally. Ensure thorough shaking before each use. Consume Mefsprit-P DS Oral Suspension with food.
Common Side effects of Mefsprit-P DS Oral Suspension:
- Nausea
- Vomiting
- Diarrhea
- Indigestion
- Loss of appetite
- Heartburn
How to use Mefsprit-P DS Oral Suspension:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Always consult the product label for complete instructions prior to consumption. Use a measuring device for accurate dosing, ingesting it orally. Ensure thorough shaking before each use. Consume Mefsprit-P DS Oral Suspension with food.
How Mefsprit-P DS Oral Suspension works:
Mefenamic acid and paracetamol, combined in Mefsprit-P DS Oral Suspension, alleviate fever, pain, and inflammation by inhibiting the production of specific inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Mefsprit-P DS Oral Suspension.
PregnancyCONSULT YOUR DOCTOR
Using Mefsprit-P DS Oral Suspension during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Mefsprit-P DS Oral Suspension presents minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent threat to the infant.
DrivingUNSAFE
Taking Mefsprit-P DS Oral Suspension might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Mefsprit-P DS Oral Suspension cautiously, potentially requiring dosage modification. Consult a physician before use. Mefsprit-P DS Oral Suspension is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Mefsprit-P DS Oral Suspension cautiously, potentially requiring dose modification. Consult a physician. Mefsprit-P DS Oral Suspension is contraindicated in individuals with severe or active liver disease.
What if you forget to take Mefsprit-P DS Oral Suspension :
Should you forget a dose of Mefsprit-P DS Oral Suspension, administer it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Mefsprit-P DS Oral Suspension
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
